FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084957583> ?p ?o ?g. }

• W2084957583 endingPage "230" @default.
• W2084957583 startingPage "229" @default.
• W2084957583 abstract "To the Editor: We studied the cardiovascular and respiratory effects of dantrolene in a 14-yr-old, 65-kg male adolescent with central core disease and a severely dilated cardiomyopathy necessitating cardiac transplantation. Central core disease is a skeletal myopathy with its gene closely linked to the malignant hyperthermia (MH) gene on chromosome 19 [1,2]. Because patients with central core disease commonly test positive for MH susceptibility, dantrolene and a non-MH-triggering anesthetic were used. However, there are significant concerns about the safe use of dantrolene in patients with preexisting skeletal muscle weakness and poor cardiac contractility due to the fact that it can cause mild to moderate skeletal muscle weakness [3] and a negative inotropic action in vitro [4,5]. Although hemodynamic depression is not normally evident in vivo when cardiovascular function is normal and compensatory hemodynamic reflexes are active [6], there have been no reports of dantrolene's cardiovascular effects either prior to or during large-dose fentanyl anesthesia in patients with greatly reduced cardiac contractility secondary to severe cardiomyopathy. In our patient, dantrolene (2.4 mg/kg) was infused over 1 h just prior to the induction of anesthesia. During the infusion, while breathing room air, the patient felt progressively weaker, complained of difficulty breathing, and became slightly lethargic but maintained SpO2 98%-100%. At the completion of the infusion, the forced vital capacity decreased from 1.9 to 1.0 L, the PaO2 declined from 104 to 73 mm Hg, and the PaCO2 remained unchanged. Heart rate, arterial blood pressure; pulmonary artery systolic, diastolic, and wedge pressure; and cardiac output all remained unchanged or slightly increased after this dantrolene infusion. Similarly, induction of anesthesia with 124 micro g/kg of fentanyl and vecuronium was hemodynamically well tolerated, as was a second dose of dantrolene (1.2 mg/kg) over the 15 min just prior to institution of bypass and a third dose (2.4 mg/kg) 8 h after successful completion of the orthotopic heart transplant (Figure 1). No intra- or postoperative triggering of MH occurred.Figure 1: Relationship between systolic blood pressure and dantrolene plasma concentrations. The first and third doses of dantrolene were infused over 1 h, and the second dose was infused over 15 min. After the completion of the first dantrolene infusion at 1 PM, fentanyl 124 micro g/kg was injected over 10 min.As shown in Figure 1, the first and second dantrolene infusions produced plasma levels in the range of 4-5 micro g/mL, which exceeded the 2.5-3.0 micro g/mL concentrations of dantrolene that have been determined to prevent MH crises and also correlate with maximum depression of the skeletal muscle twitch response [7]. The third infusion increased plasma concentrations to more than 11 micro g/mL. Hence, this case provides strong evidence that high therapeutic blood concentrations of dantrolene do not produce hemodynamic instability in patients with a severe cardiomyopathy either before or after the blunting of cardiovascular reflexes with the administration of large-dose fentanyl and that supratherapeutic blood levels of dantrolene are well tolerated in a newly transplanted heart. Douglas E. Koehntop, MD David S. Beebe, MD Kumar G. Belani, MD Department of Anesthesiology; University of Minnesota Hospital and Clinic; Minneapolis, Mn 55455" @default.
• W2084957583 created "2016-06-24" @default.
• W2084957583 creator A5024721965 @default.
• W2084957583 creator A5043129258 @default.
• W2084957583 creator A5055818487 @default.
• W2084957583 date "1997-07-01" @default.
• W2084957583 modified "2023-09-24" @default.
• W2084957583 title "The Safety of Dantrolene in a Patient with a Severe Cardiomyopathy Requiring a Heart Transplant" @default.
• W2084957583 cites W2032095844 @default.
• W2084957583 cites W2062147412 @default.
• W2084957583 cites W2078465267 @default.
• W2084957583 cites W2102316254 @default.
• W2084957583 cites W2131705023 @default.
• W2084957583 cites W2166493154 @default.
• W2084957583 doi "https://doi.org/10.1097/00000539-199707000-00049" @default.
• W2084957583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9212158" @default.
• W2084957583 hasPublicationYear "1997" @default.
• W2084957583 type Work @default.
• W2084957583 sameAs 2084957583 @default.
• W2084957583 citedByCount "6" @default.
• W2084957583 countsByYear W20849575832012 @default.
• W2084957583 countsByYear W20849575832020 @default.
• W2084957583 crossrefType "journal-article" @default.
• W2084957583 hasAuthorship W2084957583A5024721965 @default.
• W2084957583 hasAuthorship W2084957583A5043129258 @default.
• W2084957583 hasAuthorship W2084957583A5055818487 @default.
• W2084957583 hasBestOaLocation W20849575831 @default.
• W2084957583 hasConcept C111566952 @default.
• W2084957583 hasConcept C126322002 @default.
• W2084957583 hasConcept C155710745 @default.
• W2084957583 hasConcept C164705383 @default.
• W2084957583 hasConcept C2778198053 @default.
• W2084957583 hasConcept C2778797674 @default.
• W2084957583 hasConcept C2781460320 @default.
• W2084957583 hasConcept C39133596 @default.
• W2084957583 hasConcept C42219234 @default.
• W2084957583 hasConcept C519063684 @default.
• W2084957583 hasConcept C71924100 @default.
• W2084957583 hasConceptScore W2084957583C111566952 @default.
• W2084957583 hasConceptScore W2084957583C126322002 @default.
• W2084957583 hasConceptScore W2084957583C155710745 @default.
• W2084957583 hasConceptScore W2084957583C164705383 @default.
• W2084957583 hasConceptScore W2084957583C2778198053 @default.
• W2084957583 hasConceptScore W2084957583C2778797674 @default.
• W2084957583 hasConceptScore W2084957583C2781460320 @default.
• W2084957583 hasConceptScore W2084957583C39133596 @default.
• W2084957583 hasConceptScore W2084957583C42219234 @default.
• W2084957583 hasConceptScore W2084957583C519063684 @default.
• W2084957583 hasConceptScore W2084957583C71924100 @default.
• W2084957583 hasIssue "1" @default.
• W2084957583 hasLocation W20849575831 @default.
• W2084957583 hasLocation W20849575832 @default.
• W2084957583 hasLocation W20849575833 @default.
• W2084957583 hasOpenAccess W2084957583 @default.
• W2084957583 hasPrimaryLocation W20849575831 @default.
• W2084957583 hasRelatedWork W128325899 @default.
• W2084957583 hasRelatedWork W154973431 @default.
• W2084957583 hasRelatedWork W1968241641 @default.
• W2084957583 hasRelatedWork W1996640109 @default.
• W2084957583 hasRelatedWork W2010181571 @default.
• W2084957583 hasRelatedWork W2042180285 @default.
• W2084957583 hasRelatedWork W2050650740 @default.
• W2084957583 hasRelatedWork W2060550115 @default.
• W2084957583 hasRelatedWork W2356260288 @default.
• W2084957583 hasRelatedWork W4241004413 @default.
• W2084957583 hasVolume "85" @default.
• W2084957583 isParatext "false" @default.
• W2084957583 isRetracted "false" @default.
• W2084957583 magId "2084957583" @default.
• W2084957583 workType "article" @default.